SCHEMBL4156490

SCHEMBL4156490

COC(=O)c1ccc(C)c(C2CCCN2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.44
HSP90AB1 P08238 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 3/20 0.40
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
XDH P47989 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
NOTUM Q6P988 1/20 0.39
KDM4E B2RXH2 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
DPP4 P27487 2/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4151012 0.99 HSP90AA1 (0.43) HSP90AA1HSP90AB1MEN1KMT2ASMN1; SMN2
SCHEMBL4150927 0.89 MEN1 (0.47) HSP90AA1HSP90AB1MEN1KMT2ASMN1; SMN2
SCHEMBL16409252 0.85 SMN1; SMN2 (0.45) HSP90AA1HSP90AB1MEN1KMT2ASMN1; SMN2
SCHEMBL14194494 0.83 MEN1 (0.46) MEN1KMT2ASMN1; SMN2ALDH1A1ATM
SCHEMBL17782243 0.79 SMN1; SMN2 (0.40) HSP90AA1HSP90AB1MEN1KMT2ASMN1; SMN2
SCHEMBL5518454 0.79 MEN1 (0.38) MEN1KMT2ASMN1; SMN2ALDH1A1ATM
SCHEMBL31480074 0.79 SLC6A3 (0.43) HSP90AA1HSP90AB1MEN1KMT2ASMN1; SMN2
SCHEMBL17782315 0.79 MEN1 (0.42) MEN1KMT2ASMN1; SMN2ALDH1A1ATM
SCHEMBL17782313 0.79 MEN1 (0.42) MEN1KMT2ASMN1; SMN2ALDH1A1ATM
SCHEMBL13741356 0.79 ALDH1A1 (0.48) MEN1KMT2ASMN1; SMN2ALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP disclosed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885HSP90AB1 1/4885MEN1 4482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.